These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15151736)

  • 1. Canadian access to hormonal contraceptive drug choices.
    Azzarello D; Collins J
    J Obstet Gynaecol Can; 2004 May; 26(5):489-500. PubMed ID: 15151736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory approval time for hormonal contraception in Canada, the United States and the United Kingdom, 2000-2015: a retrospective data analysis.
    Troskie C; Soon JA; Albert AY; Norman WV
    CMAJ Open; 2016; 4(4):E654-E660. PubMed ID: 28018878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time required for approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States in 1996-1998.
    Rawson NS
    CMAJ; 2000 Feb; 162(4):501-4. PubMed ID: 10701383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nondaily hormonal contraception: considerations in contraceptive choice and patient counseling.
    Freeman S
    J Am Acad Nurse Pract; 2004 Jun; 16(6):226-38. PubMed ID: 15264608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug regulation in the United States and the United Kingdom: the Depo-Provera story.
    Richard BW; Lasagna L
    Ann Intern Med; 1987 Jun; 106(6):886-91. PubMed ID: 2953290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missed hormonal contraceptives: new recommendations.
    Guilbert E; Black A; Dunn S; Senikas V; ;
    J Obstet Gynaecol Can; 2008 Nov; 30(11):1050-1062. PubMed ID: 19126288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the British warning on contraceptive use in the General Medical Service in Ireland.
    Williams D; Kelly A; Carvalho M; Feely J
    Ir Med J; 1998 Dec; 91(6):202-3. PubMed ID: 10069128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
    Farmer RD; Lawrenson RA
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines and requirements for the evaluation of contraceptive steroids.
    McKenzie BE
    Toxicol Pathol; 1989; 17(2):377-84. PubMed ID: 2675288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle.
    Nelson AL
    Am J Obstet Gynecol; 1997 Jun; 176(6):1376-80. PubMed ID: 9215201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timeliness of review and approval of new drugs in Canada from 1999 through 2001: is progress being made?
    Rawson NS
    Clin Ther; 2003 Apr; 25(4):1230-47. PubMed ID: 12809970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of hormonal contraception for obese women.
    Rocha ALL; Campos RR; Miranda MMS; Raspante LBP; Carneiro MM; Vieira CS; Reis FM
    Expert Opin Drug Saf; 2017 Dec; 16(12):1387-1393. PubMed ID: 28988524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Hormonal Contraception With Suicide Attempts and Suicides.
    Skovlund CW; Mørch LS; Kessing LV; Lange T; Lidegaard Ø
    Am J Psychiatry; 2018 Apr; 175(4):336-342. PubMed ID: 29145752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
    Reid R;
    J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug and food interactions with contraceptives: CNGOF Contraception Guidelines].
    Bernier M; Jonville-Bera AP
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):786-791. PubMed ID: 30385357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Providing free pregnancy test kits to community health workers increases distribution of contraceptives: results from an impact evaluation in Madagascar.
    Comfort AB; Chankova S; Juras R; Hsi CN; Peterson LA; Hathi P
    Contraception; 2016 Jan; 93(1):44-51. PubMed ID: 26409247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
    Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
    Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drug approval times and 'therapeutic potential' in Canada, Australia, Sweden and the United States during the period 1992 to 1998.
    Rawson NS; Kaitin KI
    Can J Clin Pharmacol; 2000; 7(2):97-101. PubMed ID: 10958705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the efficacy, acceptability, and side effects of a contraceptive pill administered by the oral and the vaginal route: an international multicenter clinical trial.
    Coutinho EM; Mascarenhas I; de Acosta OM; Flores JG; Gu ZP; Ladipo OA; Adekunle AO; Otolorin EO; Shaaban MM; Abul Oyoon M
    Clin Pharmacol Ther; 1993 Nov; 54(5):540-5. PubMed ID: 8222497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.